3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
45
Terminated
6
Recruiting
6
Withdrawn
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
61
INDUSTRY
43
NIH
6
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
19
Multiple Myeloma
16
Prostatic Neoplasms
14
Carcinoma, Non-Small-Cell Lung
12
Neoplasms
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma
9
Leukemia, Myeloid, Acute
7
Lung Neoplasms
6
Leukemia, Biphenotypic, Acute
6
Squamous Cell Carcinoma of Head and Neck
5
Neuroblastoma
5
Medulloblastoma
5
Lymphoma, Mantle-Cell
5
Leukemia
5
Hodgkin Disease
5
Ependymoma
5
Colorectal Neoplasms
5
Oropharyngeal Neoplasms
4
Neoplasm Metastasis
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Burkitt Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Oligodendroglioma
3
Melanoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hematologic Neoplasms
3
Glioma
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
NETWORK
×
Lymphoma, Large B-Cell, Diffuse
×
Clear all
NCT03293173
2024-06-21
Bio-CHIC
Nordic Lymphoma Group
Phase 2
Active not recruiting
120 enrolled